Biotech Values

[Kayaker]

BIOASIS Technologies Inc. (BTI on the TSXV) -- Small Vancouver biotech. Don't see it mentioned here in a search. Small float. Compelling story. Derisking is going well so far. (Yes, I have a significant position).

Company site: http://www.BIOASIS.ca

Good videos for an overview....

May 2012 video:

Nov 2012 update:

TRANSCEND Program - Blood Brain Barrier Technology
Research previously conducted on behalf of the Company demonstrated the ability of p97 to deliver chemotherapeutic agents across the BBB in concentrations of up to ten times that of the same drugs delivered through traditional methods. Medical indications that might benefit from this type of drug delivery include brain cancer (glioblastomas and brain metastases from other cancers), neurodegenerative diseases, infections, psychiatric disorders and pain.

Latest study results from Texas Tech are expected soon. From the Oct 25, 2012 MD&A @ http://www.sedar.com/

"In January, 2012 the Company started a program at Texas Tech University Health Sciences Center (“TTUHSC”) under which a series of preclinical studies designed to evaluate the pharmacokinetics of BT2111 in animal models of breast cancer metastasis in the brain are being performed. The studies are being conducted under the direction of Drs. Quentin Smith and Paul Lockman, both recognized experts on the blood-brain barrier and in evaluating drug delivery to the central nervous system for the treatment of brain tumors...."

BTI is discussed at Stockhouse
http://tinyurl.com/aj45yeu

Four evaluative collaborations (Shire, Abbott, MedImmune, UCB) are in the works. Decisions by Shire and Abbott on obtaining a license for Transcend are expected soon. BTI is in talks with at least seven more pharmas...

http://tinyurl.com/altx3b9

A recent IR update (from a poster)...

http://tinyurl.com/a62t73q

Many of the best posts are from "pmrider" at the Stockhouse forum.

FWIW.